Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymoglobulin with Rapid Steroid Withdrawal in Renal Transplant
NCT00089947Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jun 2003
- Primary completion
- Dec 2005
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of antithymocyte globulin in kidney transplant rejection, sponsored by Sanofi. Started Jun 2003; status: completed.
02
Drugs
antithymocyte globulin
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00089947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00089947.